ProPharma is at the forefront of the life sciences industry and continues to innovate and elevate its position as the world’s largest RCO. Stay up to date on ProPharma’s latest news and most recent announcements.
February 6, 2023
On January 31st, 2023, Clinical Insider, a weekly clinical trials newsletter, published a blog post mentioning ProPharma's recent acquisition of Digital Lab Consulting (DLC) and ProPharma's release...
January 25, 2023
PROPHARMA ANNOUNCES ACQUISITION OF UK-BASED DIGITAL LAB CONSULTING TO EXPAND R&D CAPABILITIES AND ACCELERATE PRODUCT DEVELOPMENT RALEIGH, NC, January 25, 2023: ProPharma Group (ProPharma) the...
January 9, 2023
$50m investment and rebrand unveiled at J.P. Morgan Healthcare Conference as part of new global growth strategy. RALEIGH, NC, January 9, 2023: ProPharma Group – the end-to-end, global provider of...
January 9, 2023
ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting...
September 13, 2022
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the expansion of the senior leadership team to include Bryan Katz as the new Chief Strategy Officer (CSO) / Head...
September 1, 2022
Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...
